RFG Advisory LLC Raises Stock Holdings in Eli Lilly and Company (NYSE:LLY)
RFG Advisory LLC boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 13.4% in the fourth quarter, ...
Private Capital Advisors Inc. Has $334.94 Million Position in Eli Lilly and Company (NYSE:LLY)
Private Capital Advisors Inc. grew its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.1% during ...
Eli Lilly's SWOT analysis: stock poised for growth amid challenges
Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...
Business Insider on MSN6d
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Pharmaceutical Technology3h
GLP-1RA developer Metsera targets $289m IPO
Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.
Thurgood Marshall College Fund Secures $25M Grant To Boost HBCU Innovation And Sustainability
The Thurgood Marshall College Fund has received a $25 million grant by the Lilly Endowment to help fund its HBCU-focused ...
pharmaphorum1d
Lilly adds to genetic meds push with Genetic Leap alliance
In its second R&D alliance this week, Eli Lilly ... the AI company behind ChatGPT – to develop antimicrobials that can be used to treat multidrug-resistant (MDR) bacteria. Lilly's current ...
pharmaphorum5d
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
The UK medicines regulator approved Eli Lilly's Alzheimer's ... first to be cleared in the UK that address an underlying disease process in the disease. Lilly said in a statement that there ...